| 注册
首页|期刊导航|医药导报|司美格鲁肽与人血清白蛋白相互作用模式及亲和力

司美格鲁肽与人血清白蛋白相互作用模式及亲和力

苏雯 王恩娜 方帷 吴凡 程宾

医药导报2026,Vol.45Issue(4):596-602,7.
医药导报2026,Vol.45Issue(4):596-602,7.DOI:10.3870/j.issn.1004-0781.2026.04.006

司美格鲁肽与人血清白蛋白相互作用模式及亲和力

Study on the Interaction Mode and Affinity between Semaglutide and Human Serum Albumin

苏雯 1王恩娜 1方帷 1吴凡 1程宾1

作者信息

  • 1. 云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106
  • 折叠

摘要

Abstract

Objective This study comprehensively employed computer simulation molecular docking technology and surface plasmon resonance(SPR)technology to investigate the interaction between semaglutide and human serum albumin(HSA).Methods Molecular docking simulations were conducted using two software tools,Autodock Vina and Discovery Studio(DS),to reveal the structural interaction pattern between semaglutide and HSA,identifying the binding site and key amino acid residues.Additionally,to address the limitations of traditional SPR analysis methods,an innovative approach was proposed,using semaglutide as the conjugated ligand and single-cycle kinetics as the analytical method.Results In the Autodock Vina and Discovery Studio docking simulations,the affinity scores between semaglutide and HSA were-66.88 and-24.24 kJ•mol-1,respectively,indicating strong interactions.Furthermore,in the SPR-based analysis,the sensor plots from multi-cycle kinetics and single-cycle kinetics experiments both aligned with the kinetic model.Using the 1∶1 Langmuir kinetic model to fit the curves,no significant difference was observed in the binding affinity of semaglutide to HSA between the two manufacturers.Conclusions The improved SPR analysis method can measure the binding affinity more accurately and is highly consistent with the results of molecular simulation.It provides a new technical means and theoretical basis for the development of GLP-1 analogues.

关键词

司美格鲁肽/人血清白蛋白/分子对接/表面等离子共振技术

Key words

Semaglutide/Human serum albumin/Molecular docking/Surface plasmon resonance technology

分类

医药卫生

引用本文复制引用

苏雯,王恩娜,方帷,吴凡,程宾..司美格鲁肽与人血清白蛋白相互作用模式及亲和力[J].医药导报,2026,45(4):596-602,7.

基金项目

药品监管科学全国重点实验室课题(2025SKLDRS0312). (2025SKLDRS0312)

医药导报

1004-0781

访问量0
|
下载量0
段落导航相关论文